Multi-Modality Diagnostic Imaging of the Eye

Precision, Detail, and Versatility

Multi-modality imaging with SPECTRALIS^® is helping drive the development of novel therapeutics and changing the course of patient management in eye care. Using an upgradeable platform approach, SPECTRALIS has enhanced the role of spectral-domain OCT by integrating it with confocal scanning laser ophthalmoscopy (cSLO). The combination of these two technologies has enabled new imaging capabilities, such as TruTrack™ active eye tracking, and BluePeak™ blue laser autofluorescence, providing clinicians with unique views of the structure and function of the eye.

Enhanced anatomical details, 1 micron measurable change¹ and automatic rescan at follow-up are the direct benefits of TruTrack™ active eye tracking and simultaneous dual-beam imaging. These two technologies are at the core of the SPECTRALIS product platform. Enhanced image detail comes from Heidelberg Noise Reduction™, which improves images like Dolby^® noise reduction improves recorded sound. Measuring change with 1 micron reproducibility is possible with AutoRescan™, which automatically places follow-up scans in precisely the same location, bypassing operator variability. This precision is the product of 20 years of proven HRT technology, which paved the way for the dual-beam approach to imaging.

The SPECTRALIS platform includes multiple models at various price points. The workhorse model in the family is the SPECTRALIS OCT, an economical, easy-to-use version with one-touch pre-set scan patterns and AutoRescan. Additional models built upon this base platform allow clinicians to tailor a system to the current needs of the practice. As the practice grows, upgrade options allow the SPECTRALIS system to grow along with it.